<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="136117">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01828580</url>
  </required_header>
  <id_info>
    <org_study_id>AL-65-001</org_study_id>
    <nct_id>NCT01828580</nct_id>
  </id_info>
  <brief_title>Safety and Performance Evaluation of the AutoLap System</brief_title>
  <official_title>Safety and Performance Evaluation of the AutoLap System - a Feasibility Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>MST Medical Surgery Technologies</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>MST Medical Surgery Technologies</source>
  <oversight_info>
    <authority>Netherlands: Dutch Health Care Inspectorate</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main objectives of this study are to evaluate the safety and performance of the AutoLap
      system in Laparoscopic Cholecystectomy procedures.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2012</start_date>
  <completion_date type="Anticipated">July 2014</completion_date>
  <primary_completion_date type="Anticipated">June 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Supportive Care</study_design>
  <primary_outcome>
    <measure>Adverse events</measure>
    <time_frame>participants will be followed for the duration of hospital stay, an expected average of 1-2 days</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>No conversion to open surgery from laparoscopic surgery due to using the AutoLap system 2) No AutoLap system related operative complications, that require further clinical intervention</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Performance evaluation</measure>
    <time_frame>during surgery -defined as the time from the first abdominal incision until the surgical procedure is completed (skin incisions are closed).</time_frame>
    <safety_issue>No</safety_issue>
    <description>The ability of the AutoLap system to successfully move the laparoscope to the surgeon's desired position</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>system set-up time</measure>
    <time_frame>during surgery - defined as the time from the first abdominal incision until the surgical procedure is completed (skin incisions are closed).</time_frame>
    <safety_issue>No</safety_issue>
    <description>defined as the time required from connecting the AutoLap's ARM to the bed rail</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Average total procedure time</measure>
    <time_frame>during surgery - defined as the time from the first abdominal incision until the surgical procedure is completed (skin incisions are closed).</time_frame>
    <safety_issue>No</safety_issue>
    <description>defined as the time from first abdominal incision until the surgical procedure is completed</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of times that the laparoscope was removed for cleaning</measure>
    <time_frame>During surgery - defined as the time from the first abdominal incision until the surgical procedure is completed (skin incisions are closed).</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Usability evaluation</measure>
    <time_frame>During surgery (at the end of the procedure)</time_frame>
    <safety_issue>No</safety_issue>
    <description>the AutoLap system usability in laparoscopic procedures will be assessed by a questionnaire. The questionnaire assesses the surgeon's satisfaction with the use of the AutoLap in regard to easiness of use, convenient of movement control and its ability to be used in the OR without interfering with the surgical flow</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Patients Scheduled for Hernia Repair, Cholecystectomy, Right Colectomy, Nissen Fundoplication and Sigmoid Resection</condition>
  <arm_group>
    <arm_group_label>AutoLap</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>active laparoscope positioner (AutoLap)</intervention_name>
    <arm_group_label>AutoLap</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Signed and dated Informed Consent Form.

          2. Patients between 18 and 75 years of age inclusive who were scheduled for elective
             laparoscopic Cholecystectomy procedure.

        Exclusion Criteria:

          1. Previous upper abdominal surgery and contraindications to Pneumoperitoneum.

          2. Pregnancy.

          3. Obesity (BMI &gt;35 Kg/m2).

          4. Generalized peritonitis.

          5. Septic shock from cholangitis.

          6. Severe acute pancreatitis.

          7. Uncorrected coagulopathy.

          8. Previous abdominal operations which prevent safe abdominal access or progression of
             the procedure.

          9. Advanced cirrhosis with failure of hepatic function.

         10. Suspected gallbladder cancer.

         11. Acute cholecystitis

         12. Presence of any medical or psychiatric condition or any other condition that, in the
             opinion of the Investigator, could affect the successful participation of the patient
             in the study.

         13. Patient participates in any other clinical study 60 days prior to the start of the
             study and throughout the study duration.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Dafna Carmi-Yinon, M.Sc.</last_name>
    <phone>+972 (0) 73-796-5570</phone>
    <email>dafna@mst-sys.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Assuta Medical Center</name>
      <address>
        <city>Tel Aviv</city>
        <zip>69710</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amir Szold, MD</last_name>
      <phone>972-37645444</phone>
      <email>amikisz@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Amir Szold, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Niguarda CÃ  Granda Hospital</name>
      <address>
        <city>Milano</city>
        <zip>20162</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antonello Forgione, MD</last_name>
      <phone>+390264447600</phone>
      <email>Antonello.Forgione@aimsacademy.org</email>
    </contact>
    <investigator>
      <last_name>Antonello Forgione, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Meander Medisch Centrum</name>
      <address>
        <city>Amersfoort</city>
        <zip>3800BM</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ivo A. M. J. Broeders, MD</last_name>
      <phone>+31338501167</phone>
      <email>IAMJ.Broeders@meandermc.nl</email>
    </contact>
    <investigator>
      <last_name>Ivo A. M. J. Broeders, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
    <country>Italy</country>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 30, 2014</lastchanged_date>
  <firstreceived_date>April 3, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>laparoscopic Cholecystectomy</keyword>
  <keyword>Gallbladder removal</keyword>
  <keyword>laparoscope holder</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hernia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
